Next Article in Journal
Antibody-Negative Paraneoplastic Autoimmune Multiorgan Syndrome (PAMS) in a Patient with Follicular Lymphoma Accompanied by an Excess of Peripheral Blood CD8+ Lymphocytes
Next Article in Special Issue
Robot-Assisted Radical Prostatectomy for Potential Cancer Control in Patients with Metastatic Prostate Cancer
Previous Article in Journal
Whole-Exome Sequencing Identifies the VHL Mutation (c.262T > C, p.Try88Arg) in Non-Obstructive Azoospermia-Associated Cystic Renal Cell Carcinoma
 
 
Article
Peer-Review Record

Concordance between Preoperative mpMRI and Pathological Stage and Its Influence on Nerve-Sparing Surgery in Patients with High-Risk Prostate Cancer

Curr. Oncol. 2022, 29(4), 2385-2394; https://doi.org/10.3390/curroncol29040193
by Clara Humke 1,*,†, Benedikt Hoeh 1,2,*,†, Felix Preisser 1, Mike Wenzel 1, Maria N. Welte 1, Lena Theissen 1, Boris Bodelle 3, Jens Koellermann 4, Thomas Steuber 5, Alexander Haese 5, Frederik Roos 1, Luis Alex Kluth 1, Andreas Becker 1, Felix K. H. Chun 1 and Philipp Mandel 1
Reviewer 1:
Reviewer 2:
Curr. Oncol. 2022, 29(4), 2385-2394; https://doi.org/10.3390/curroncol29040193
Submission received: 27 February 2022 / Revised: 22 March 2022 / Accepted: 25 March 2022 / Published: 28 March 2022
(This article belongs to the Special Issue Surgery for Prostate Cancer: Recent Advances and Future Directions)

Round 1

Reviewer 1 Report

The work is overall well written and leads to shareable conclusions.

Although the mpMRI still has wide margins of uncertainty for the local staging of prostate cancer it remains an essential tool, from reading the work its role comes out a little too reduced.

I would like to point out that the message that must pass is not so much that in real life an mpMRI must be done just to do it but that in patients with high-risk disease it is essential.

It is right to specify that the mpMRIs were not reviewed centrally but it is equally important to assert that, especially for patients with high-risk disease, it is right to manage the cases in a multidisciplinary context, possibly with revision of the radiological examinations by dedicated radiologists.

It should also be noted that for patients with high-risk disease the surgical choice must be shared with the patient, specifying that it probably represents the stage of a multimodal path that will probably also include radiotherapy.

All this in the premises of the work does not seem well clarified.

I would add to the references also this one that reaches some conclusions a little different from those mentioned in the work:
Jäderling, F., Akre, O., Aly, M. et al. Preoperative staging using magnetic resonance imaging and risk of positive surgical margins after prostate-cancer surgery. Prostate Cancer Prostatic Dis 22, 391–398 (2019). https://doi.org/10.1038/s41391-018-0116-z

Overall, with the necessary clarifications, the work deserves publication as it addresses an important topic of study regarding the possibility of limiting the side effects of surgery even in patients with high-risk disease.

Author Response

Please see the attachment.

Reviewer 2 Report

This study presents some important findings regarding the use of mpMRI preoperatively to detect patients who are suitable for NSS vs those who are note.

The results are interesting and reasonable according to clinical reasoning, since depending only on mpMRI to support NSS or not is not a common practice. However, results are presented with many numbers which may be too frustrating for the average reader. Therefore I believe that a graph showing the main findings of the study would be a very useful addition.

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Back to TopTop